ArticleDiabetes2009

ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.

Anne Hiukka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.